These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37550264)

  • 1. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
    Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
    Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses.
    Mahapatro A; Bawna F; Kumar V; Daryagasht AA; Gupta S; Raghuma N; Moghdam SS; Kolla A; Mahapatra SS; Sattari N; Amini-Salehi E; Nayak SS
    Clin Nutr ESPEN; 2023 Oct; 57():475-486. PubMed ID: 37739694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
    Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
    Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.
    Naghipour A; Amini-Salehi E; Orang Gorabzarmakhi M; Shahdkar M; Fouladi B; Alipourfard I; Sanat ZM
    Syst Rev; 2023 Aug; 12(1):144. PubMed ID: 37605283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.
    Vakilpour A; Amini-Salehi E; Soltani Moghadam A; Keivanlou MH; Letafatkar N; Habibi A; Hashemi M; Eslami N; Zare R; Norouzi N; Delam H; Joukar F; Mansour-Ghanaei F; Hassanipour S; Samethadka Nayak S
    Nutr Diabetes; 2024 May; 14(1):25. PubMed ID: 38729941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials.
    Amini-Salehi E; Samethadka Nayak S; Maddineni G; Mahapatro A; Keivanlou MH; Soltani Moghadam S; Vakilpour A; Aleali MS; Joukar F; Hashemi M; Norouzi N; Bakhshi A; Bahrampourian A; Mansour-Ghanaei F; Hassanipour S
    Ann Med Surg (Lond); 2024 May; 86(5):2900-2910. PubMed ID: 38694388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
    Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
    Pan Y; Yang Y; Wu J; Zhou H; Yang C
    BMC Gastroenterol; 2024 Aug; 24(1):283. PubMed ID: 39174901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis.
    Li S; Liu J; Wang Z; Duan F; Jia Z; Chen X; Li S
    Front Public Health; 2022; 10():862266. PubMed ID: 35958869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
    Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
    Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Liu L; Li P; Liu Y; Zhang Y
    Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
    Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ
    World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials.
    Wang MY; Prabahar K; Găman MA; Zhang JL
    J Dig Dis; 2023; 24(6-7):380-389. PubMed ID: 37503812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis.
    Musazadeh V; Roshanravan N; Dehghan P; Ahrabi SS
    Front Nutr; 2022; 9():844242. PubMed ID: 35677540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.
    Ma J; Zhou Q; Li H
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 29035308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.